Increased methylmercury toxicity related to obesity in diabetic KK-Ay mice

Journal of Applied Toxicology

Volumn 34, Issue 8, 2014, Pages 914-923

  Yamamoto, Megumi ^a   Yanagisawa, Rie ^a,d   Motomura, Eriko ^a   Nakamura, Masaaki ^a   Sakamoto, Mineshi ^a   Takeya, Motohiro ^b   Eto, Komyo ^c  

^a NATIONAL INSTITUTE FOR MINAMATA DISEASE   (Japan)

^b KUMAMOTO UNIVERSITY   (Japan)

^c Health and Nursing Facilities for the Aged Jushindai Shinwakai   (Japan)

^d NATIONAL INSTITUTE FOR ENVIRONMENTAL STUDIES   (Japan)

Author keywords

CD204; Diabetes; Methylmercury; Neurotoxicity; Obesity

Indexed keywords

MERCURY; METHYLMERCURY; GLUCOSE BLOOD LEVEL; METHYLMERCURY DERIVATIVE;

ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY FAT; BODY WEIGHT; BRAIN; CLINICAL EXAMINATION; CONTROLLED STUDY; EPIDIDYMIS FAT; KIDNEY; MACROPHAGE; MALE; MOUSE; NEUROLOGIC DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; OBSERVATIONAL STUDY; PANCREAS; PRIORITY JOURNAL; RAT; SPLEEN; TARGET ORGAN; TISSUE INJURY; TREATMENT DURATION; ANIMAL; BLOOD; C57BL MOUSE; CHEMICALLY INDUCED; COMPLICATION; DRUG EFFECTS; GLUCOSE BLOOD LEVEL; IMMUNOHISTOCHEMISTRY; METABOLISM; PATHOLOGY; TOXICITY;

MUS;

ADIPOSE TISSUE; ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; BRAIN; DIABETES MELLITUS, TYPE 2; IMMUNOHISTOCHEMISTRY; KIDNEY; MALE; METHYLMERCURY COMPOUNDS; MICE; MICE, INBRED C57BL; OBESITY; PANCREAS; SPLEEN;

EID: 84903157303     PISSN: 0260437X     EISSN: 10991263     Source Type: Journal    
DOI: 10.1002/jat.2954     Document Type: Article

References (36)

1. Buffet PA, Safeukui I, Deplaine G, Brousse V, Prendki V, Thellier M, Turner GD, Mercereau-Puijalon O. 2010. The pathogenesis of Plasmodium falciparum malaria in humans: insights from splenic physiology. Blood 117(2): 381-392.
2. Cade WT. 2008. Diabetes-related microvascular and macrovascular diseases in the physical therapy setting. Phys. Ther. 88(11): 1322-1335.
3. Chen L, Magliano DJ, Zimmet PZ. 2011. The worldwide epidemiology of type 2 diabetes mellitus - present and future perspectives. Nat. Rev. Endocrinol. 8(4): 228-236.
4. Chen YW, Huang CF, Tsai KS, Yang RS, Yen CC, Yang CY, Lin-Shiau SY, Liu SH. 2006. The role of phosphoinositide 3-kinase/Akt signaling in low-dose mercury-induced mouse pancreatic beta-cell dysfunction in vitro and in vivo. Diabetes 55(6): 1614-1624.
5. Ekstrand J, Nielsen JB, Havarinasab S, Zalups RK, Soderkvist P, Hultman P. 2009. Mercury toxicokinetics - dependency on strain and gender. Toxicol. Appl. Pharmacol. 243(3): 283-291.
6. Eto K. 1997. Pathology of Minamata disease. Toxicol. Pathol. 25(6): 614-623.
7. Eto K, Yasutake A, Miyamoto K, Tokunaga H, Otsuka H, Hultman Y. 1997. Chronic effects of methylmercury in rats. II. Pathological aspects. Tohoku J. Exp. Med. 182(3): 197-205.
8. Fukuhara-Takaki K, Sakai M, Sakamoto Y, Takeya M, Horiuchi S. 2005. Expression of class A scavenger receptor is enhanced by high glucose in vitro and under diabetic conditions in vivo: one mechanism for an increased rate of atherosclerosis in diabetes. J. Biol. Chem. 280(5): 3355-3364.
9. Gage EL. 1962. Experiences with surgery of the sympathetic nervous system; (with case reports). W. V. Med. J. 58: 195-203.
10. Guyenet SJ, Furrer SA, Damian VM, Baughan TD, La Spada AR, Garden GA. 2010. A simple composite phenotype scoring system for evaluating mouse models of cerebellar ataxia. J. Vis. Exp. 39: 1787.
11. He K, Xun P, Liu K, Morris S, Reis J, Guallar E. 2013. Mercury exposure in young adulthood and incidence of diabetes later in life: The CARDIA Trace Element Study. Diabetes Care 36(6): 1584-1589.
12. Husemann J, Loike JD, Anankov R, Febbraio M, Silverstein SC. 2002. Scavenger receptors in neurobiology and neuropathology: their role on microglia and other cells of the nervous system. Glia 40(2): 195-205.
13. Imai Y, Kohsaka S. 2002. Intracellular signaling in M-CSF-induced microglia activation: role of Iba1. Glia 40(2): 164-174.
14. Jacobs MB, Yamaguchi S, Goldwater LJ, Gilbert H. 1960. Determination of mercury in blood. Am. Ind. Hyg. Assoc. J. 21: 475-480.
15. Kigerl KA, Gensel JC, Ankeny JK, Alexander DJ, Donnelly PG. 2009. Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. J. Neurosci. 29(43): 13435-13444.
16. Min LG, Mogi M, Shudou M, Jing F, Tsukuda K, Ohshima K, Iwanami J, Horiuchi M. 2012. Peroxisome proliferator-activated receptor-gamma activation with angiotensin II type 1 receptor blockade is pivotal for the prevention of blood-brain barrier impairment and cognitive decline in type 2 diabetic mice. Hypertension 59(5): 1079-1088.
17. Mori N, Yamamoto M, Tsukada E, Yokooji T, Matsumura N, Sasaki M, Murakami T. 2012. Comparison of in vivo with in vitro pharmacokinetics of mercury between methylmercury chloride and methylmercury cysteine using rats and Caco2 cells. Arch. Environ. Contam. Toxicol. 63(4): 628-636.
18. Negi G, Kumar A, Joshi RP, Sharma SS. 2010. Oxidative stress and Nrf2 in the pathophysiology of diabetic neuropathy: old perspective with a new angle. Biochem. Biophys. Res. Commun. 408: 1-5.
19. Nielsen JB. 1992. Toxicokinetics of mercuric chloride and methylmercuric chloride in mice. J. Toxicol. Environ. Health 37: 85-122.
20. Nielsen JB, Andersen O. 1991. Methyl mercuric chloride toxicokinetics in mice. I: Effects of strain, sex, route of administration and dose. Pharmacol. Toxicol.. 68(3): 201-207.
21. Nishimura M. 1969. Breeding of mice strains for diabetes mellitus. Exp. Anim. 18: 147-157.
22. Nyland JF, Fillion M, Barbosa F Jr., Shirley DL, Chine C, Lemire M, Mergler D, Silbergeld EK. 2011. Biomarkers of methylmercury exposure immunotoxicity among fish consumers in Amazonian Brazil. Environ. Health Perspect. 119(12): 1733-1738.
23. Okabe M, Takeuchi T. 1980. Distribution and fate of mercury in tissue of human organs in Minamata disease. Neurotoxicology 1: 607-624.
24. Sakamoto M, Kakita A, de Oliveira RB, Sheng Pan H, Takahashi H. 2004. Dose-dependent effects of methylmercury administered during neonatal brain spurt in rats. Brain Res. Dev. Brain Res. 152(2): 171-176.
25. Takeuchi T, Eto K. 1999. List of Autopsy Cases from the Methylmercury-Polluted Area. In: The Pathology Minamata Disease - a Tragic Story of Water Pollution, Nakayama H, Sumiyoshi A (eds). Kyushu University Press: Fukuoka; 226-282.
26. Tamashiro H, Arakaki M, Akagi H, Futatsuka M, Roht LH. 1985. Mortality and survival for Minamata disease. Int. J. Epidemiol. 14(4): 582-588.
27. Tang Y, Osawa H, Onuma H, Nishimiya M, Ochi T, Makino H. 2001. Adipocyte-specific reduction of phosphodiesterase 3B gene expression and its restoration by JTT-501 in the obese, diabetic KKAy mouse. Eur. J. Endocrinol. 145: 93-99.
28. Teraoka N, Mutoh M, Takasu S, Ueno T, Nakano K, Takahashi M, Imai T, Masuda S, Sugimura T, Wakabayashi K. 2010. High susceptibility to azoxymethane-induced colorectal carcinogenesis in obese KK-Ay mice. Int. J. Cancer 129(3): 528-535.
29. Toyama T, Shinkai Y, Yasutake A, Uchida K, Yamamoto M, Kumagai Y. 2011. Isothiocyanates reduce mercury accumulation via an Nrf2-dependent mechanism during exposure of mice to methylmercury. Environ. Health Perspect. 119(8): 1117-1122.
30. Uchino M, Tanaka Y, Ando Y, Yonehara T, Hara A, Mishima I, Okajima T, Ando M. 1995. Neurologic features of chronic Minamata disease (organic mercury poisoning) and incidence of complications with aging. J. Environ. Sci. Health B 30(5): 699-715.
31. Wang Y, Harris DC. 2011. Macrophages in renal disease. J. Am. Soc. Nephrol. 22: 21-27.
32. WHO. 2008. Guidance for Identifying Populations at Risk from Mercury Exposure. WHO: Geneva.
33. WHO. 2010. Children's Exposure to Mercury Compounds. WHO: Geneva.
34. WHO. 2011. Diabetes Fact Sheet N°312. WHO: Geneva.
35. Yabuki A, Taniguchi K, Yamato O. 2010. Immunohistochemical examination of cyclooxygenase-2 and renin in a KK-A(y) mouse model of diabetic nephropathy. Exp. Anim. 59(4): 479-486.
36. Yamamoto M, Takeya M, Ikeshima-Kataoka H, Yasui M, Kawasaki Y, Shiraishi M, Majima E, Shiraishi S, Uezono Y, Sasaki M, Eto K. 2012. Increased expression of aquaporin-4 with methylmercury exposure in the brain of the common marmoset. J. Toxicol. Sci. 37(4): 749-763.